ArticleGastroenterology & hepatology2021
A Phase 2 Clinical Trial of the Phosphatidylserine-Targeting Antibody Bavituximab in Combination With Pembrolizumab in Patients With Advanced Hepatocellular Carcinoma.
No numbers read from the abstract.
1 paper cites it
this papercites it